The Industry Analysis of Indian Diabetes Market with Trends and  Segmentation
                     The Industry Analysis of Indian 
Diabetes  Market with Trends and 
TShee digabemtes leanndsctapae tini Inodina is rapidly evolving, with a growing number of people 
affected by  this chronic condition. This concerning growth is fueled by a rising 
number of diabetes cases  and a growing awareness of the condition. The 
diabetes market size in India was USD 18.5  billion in 2023. This figure is projected to 
reach a concerning USD 32.2 billion by 2028,  reflecting a CAGR of 10.3%.
Growth Factor
This alarming growth is fueled by several 
factors:
● Rising Prevalence of Diabetes: India is dubbed the "diabetes capital of the 
world," with  an estimated 77 million people living with diabetes . This 
number is expected to rise  further due to factors like urbanization, unhealthy 
lifestyles, and an aging population.
● Growing Awareness and Diagnosis: Increased awareness of diabetes and 
improved  diagnostic facilities are leading to earlier detection and 
management of the condition.
● Lifestyle Changes and Dietary Factors: A shift towards processed foods, 
reduced  physical activity, and increasing obesity contribute to the rising 
diabetes burden.
Diabetes Market Segmentation
The diabetes market segmentation into various categories catering to different 
aspects of  diabetes management:
● Diabetes Therapeutics Market : This segment encompasses oral 
medications like  metformin and injectable drugs like insulin used to 
control blood sugar levels.
● Diabetes Care Devices Market : This segment includes blood glucose 
monitoring  devices, insulin pumps, and continuous glucose monitoring 
(CGM) systems to help  patients track and manage their condition.
● Digital Diabetes Management Market : Telemedicine platforms, mobile health 
apps, and  wearable devices are revolutionizing diabetes management by 
offering remote  monitoring, personalized coaching, and data-driven insights.
● Diabetic Neuropathy Market : This segment focuses on medications and 
therapies for  managing diabetic neuropathy, a common complication 
characterized by nerve damage.
● Diabetes Drug Market: The diabetes drug market is a vital component 
of diabetes  management. Here's a breakdown of key areas:
● Type 2 Diabetes Drugs : Medications like metformin, DPP-4 inhibitors, 
and SGLT-2  inhibitors are used to manage blood sugar levels in type 2 
diabetes, the most  prevalent form in India.
● Type 1 Diabetes Drugs: Insulin remains the primary treatment for type 1 
diabetes, a  condition where the body produces little to no insulin.
Take a look at: The Global Digital Diabetes Management Market Analysis to 2028
Top Players
The Indian diabetes market is a dynamic landscape with established 
domestic and  international players:
● Sun Pharmaceutical Industries Ltd (estimated market share of 20%): A 
leading  Indian pharmaceutical company with a strong presence in the 
diabetes drug market.
● Abbott Laboratories (estimated market share of 15%): A global healthcare 
company  offering a range of diabetes care devices and continuous glucose 
monitoring systems.
● Johnson & Johnson (estimated market share of 12%): This multinational 
healthcare  giant offers blood glucose monitoring devices and diabetes 
management solutions.
● Eli Lilly and Company (estimated market share of 10%): A leading 
pharmaceutical  company with a strong portfolio of insulin products for 
diabetes management.
● Dr. Reddy's Laboratories Ltd (estimated market share of 8%): Another 
prominent  Indian pharmaceutical company with a growing presence in the 
diabetes drug market.
Trends Shaping the Future of Diabetes Management
The diabetes market trends that will shape its future:
● Focus on Affordable Innovations: This can involve developing generic drugs, 
biosimilar  insulins, and mobile health solutions that cater to the specific 
needs of the Indian market.
● Rise of Telemedicine and Digital Solutions: Remote consultations with 
diabetes  specialists and data-driven insights from wearable devices will 
empower patients to  manage their condition more effectively.
● Personalized Medicine and Precision Care: Tailoring treatment plans based on 
individual  genetic profiles and health data will lead to more targeted and 
effective diabetes  management strategies.
● Focus on Preventive Care and Lifestyle Management: Promoting healthy 
eating habits,  regular physical activity, and early risk assessment can help 
prevent or delay the onset  of type 2 diabetes.
Conclusion
The Indian diabetes industryreflects the growing need for effective diabetes 
management  solutions. By addressing challenges, embracing innovation, and 
focusing on prevention,  stakeholders can create a future where diabetes doesn't 
limit the lives of millions in India. This  requires a collaborative effort from 
government bodies, healthcare professionals, the  pharmaceutical industry, and 
individuals to promote awareness, support healthy choices, and  ensure access to 
quality care for all.
You can also read about: Global Diabetes Drugs Market Trends, 
Opportunities and  Segmentation